Nocturnal sleep EEG in patients with HIV infection.
Nocturnal sleep was studied in 14 human immunodeficiency virus (HIV)-positive patients without opportunistic infections of the central nervous system. Seven patients had no bodily complaints at the time of the investigation. Patients exhibited an impaired nocturnal sleep with longer sleep onset latency, reduced total sleep time, reduced sleep efficiency, and more time spent awake and in stage 1. Stage 2 sleep was significantly decreased; in 2 cases, sleep spindle density was extremely low. REM latency was reduced and correlated negatively with depressive symptomatology, while the percentages of REM and slow wave sleep were normal. No significant differences in sleep parameters were present among patients in different stages of the illness, or between patients with and without bodily complaints. Ventricular size and sulcal width on computed tomography scans correlated with sleep variables indicating reduced sleep quality, and with REM density. Decreased tryptophan plasma levels were associated with shorter and less efficient sleep, and with reduced stage 2 sleep. The findings demonstrate that sleep EEG investigations can be valuable for detecting and monitoring central nervous system affection in HIV-positive individuals.
Wiegand
M
M
Max-Planck-Institut für Psychiatrie, Klinisches Institut, Munich, Federal Republic of Germany.
Möller
A A
AA
Schreiber
W
W
Krieg
J C
JC
Fuchs
D
D
Wachter
H
H
Holsboer
F
F
D015526:AIDS Dementia Complex / Q000175:diagnosis / Q000503:physiopathology; D000328:Adult; D001143:Arousal / Q000502:physiology*; D002940:Circadian Rhythm / Q000502:physiology*; D004569:Electroencephalography; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000503:physiopathology*; D006679:HIV Seropositivity / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012701:Serotonin / Q000502:physiology; D012894:Sleep Stages / Q000502:physiology*; D014364:Tryptophan / Q000378:metabolism
D012701:Serotonin; D014364:Tryptophan